Northern Trust’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.83M Buy
985,435
+136,966
+16% +$1.09M ﹤0.01% 2143
2025
Q4
$5.12M Sell
848,469
-58,657
-6% -$349K ﹤0.01% 2467
2025
Q3
$5.18M Sell
907,126
-21,114
-2% -$108K ﹤0.01% 2479
2025
Q2
$4.68M Sell
928,240
-2,080
-0.2% -$11.2K ﹤0.01% 2492
2025
Q1
$6.03M Sell
930,320
-134
-0% -$1.19K ﹤0.01% 2323
2024
Q4
$6.83M Buy
930,454
+51,530
+6% +$406K ﹤0.01% 2337
2024
Q3
$6.58M Buy
878,924
+45,433
+5% +$395K ﹤0.01% 2319
2024
Q2
$7.42M Sell
833,491
-25,100
-3% -$241K ﹤0.01% 2167
2024
Q1
$8.7M Sell
858,591
-78,713
-8% -$802K ﹤0.01% 2126
2023
Q4
$9.43M Sell
937,304
-61,249
-6% -$560K ﹤0.01% 2119
2023
Q3
$9.36M Buy
998,553
+21,808
+2% +$311K ﹤0.01% 2056
2023
Q2
$24M Buy
976,745
+110,365
+13% +$2.77M ﹤0.01% 1465
2023
Q1
$20.2M Buy
866,380
+87,681
+11% +$2.24M ﹤0.01% 1541
2022
Q4
$19.7M Sell
778,699
-51,965
-6% -$1.27M ﹤0.01% 1531
2022
Q3
$16M Sell
830,664
-23,739
-3% -$603K ﹤0.01% 1649
2022
Q2
$21.8M Buy
854,403
+243,076
+40% +$5.67M ﹤0.01% 1465
2022
Q1
$15.7M Sell
611,327
-8,180
-1% -$243K ﹤0.01% 1843
2021
Q4
$25.9M Sell
619,507
-3,142
-0.5% -$123K ﹤0.01% 1588
2021
Q3
$27.1M Sell
622,649
-28,611
-4% -$1.24M ﹤0.01% 1568
2021
Q2
$30.8M Buy
651,260
+46,639
+8% +$2.12M 0.01% 1570
2021
Q1
$31M Sell
604,621
-32,392
-5% -$1.75M 0.01% 1508
2020
Q4
$17.1M Sell
637,013
-17,808
-3% -$579K ﹤0.01% 1905
2020
Q3
$22.5M Buy
654,821
+164,032
+33% +$7.06M ﹤0.01% 1533
2020
Q2
$20.1M Buy
490,789
+381,561
+349% +$12.8M ﹤0.01% 1620
2020
Q1
$3.74M Buy
109,228
+3,476
+3% +$93.4K ﹤0.01% 2471
2019
Q4
$1.33M Buy
+105,752
New +$1.42M ﹤0.01% 3300

Other funds holding VIR